K. Fizazi, G. Gravis, A. Flechon, L. Geoffrois, C. Chevreau, et al.. Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial.
Annals of Oncology, Oxford University Press (OUP), 2014, 25, pp.987--91.
⟨10.1093/annonc/mdu099⟩.
⟨hal-02168058⟩